GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.900
-0.030 (-0.61%)
At close: Jun 27, 2025, 4:00 PM
4.800
-0.100 (-2.04%)
After-hours: Jun 27, 2025, 6:53 PM EDT
GoodRx Holdings Market Cap
GoodRx Holdings has a market cap or net worth of $1.88 billion as of June 27, 2025. Its market cap has decreased by -43.77% in one year.
Market Cap
1.88B
Enterprise Value
2.12B
1-Year Change
-43.77%
Ranking
Category
Stock Price
$4.90
Market Cap Chart
Since the IPO on September 23, 2020, GoodRx Holdings's market cap has decreased from $12.67B to $1.88B, a decrease of -85.17%. That is a compound annual growth rate of -33.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 1.89B | 5.69% |
| Dec 31, 2024 | 1.79B | -34.24% |
| Dec 29, 2023 | 2.72B | 47.38% |
| Dec 30, 2022 | 1.85B | -85.84% |
| Dec 31, 2021 | 13.04B | -17.43% |
| Dec 31, 2020 | 15.79B | 24.57% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |